• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Characterization of H5N1 avian influenza virus isolated from bird in Russia with the E627K mutation in the PB2 protein

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Nov 3;14(1):26490.
doi: 10.1038/s41598-024-78175-y. Characterization of H5N1 avian influenza virus isolated from bird in Russia with the E627K mutation in the PB2 protein

Vasiliy Yu Marchenko[SUP] 1 [/SUP], Anastasia S Panova[SUP] 2 [/SUP], Natalia P Kolosova[SUP] 2 [/SUP], Andrey S Gudymo[SUP] 2 [/SUP], Svetlana V Svyatchenko[SUP] 2 [/SUP], Alexey V Danilenko[SUP] 2 [/SUP], Natalia N Vasiltsova[SUP] 2 [/SUP], Marina L Egorova[SUP] 2 [/SUP], Galina S Onkhonova[SUP] 2 [/SUP], Pavel D Zhestkov[SUP] 3 [/SUP], Nikolay G Zinyakov[SUP] 3 [/SUP], Dmitriy B Andreychuk[SUP] 3 [/SUP], Ilya A Chvala[SUP] 3 [/SUP], Maksim N Kosenko[SUP] 2 [/SUP], Anastasia A Moiseeva[SUP] 2 [/SUP], Nikita D Boldyrev[SUP] 2 [/SUP], Kiunnei N Shadrinova[SUP] 2 [/SUP], Olga N Perfilieva[SUP] 2 [/SUP], Alexander B Ryzhikov[SUP] 2 [/SUP]



Affiliations
Abstract

Currently A(H5Nx) avian influenza viruses are globally widespread and continue to evolve. Since their emergence in 2020 novel highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b reassortant viruses have become predominant in the world and caused multiple infections in mammals. It was shown that some of A(H5N1) viruses mostly isolated from mammals contain an E627K mutation in the PB2 protein which can lead to adaptation of influenza viruses to mammalian cells. In 2023 in Russia we have isolated two highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b viruses from birds one of which contained an E627K mutation in the PB2 protein. This virus had increased virulence in mice. Limited airborne transmission of the virus with the PB2-E627K mutation was observed between ferrets, in which infectious virus was detected in the nasal washings of the three of the twelve recipient ferrets, and clinical symptoms of the disease were observed in one case. Both viruses showed dominant binding to avian-type sialoside receptors, which was most likely the reason for the limited transmissibility. Thus, this study indicates a possible limited increase in the pandemic potential of A(H5N1) 2.3.4.4b viruses and highlights the importance of continuous avian influenza surveillance for pandemic preparedness and response.


 
Back
Top Bottom